Lovejoy DB[au] - Search Results

Year	Number of Results
1975	1
2000	2
2002	1
2003	4
2004	2
2006	3
2007	1
2008	2
2009	6
2010	5
2011	5
2012	4
2013	3
2014	1
2015	1
2016	2
2017	2
2018	5
2019	4
2020	4
2021	1
2022	4
2023	1
2024	0

1

Brain Co-Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy.

Zou Y, Wang Y, Xu S, Liu Y, Yin J, Lovejoy DB, Zheng M, Liang XJ, Park JB, Efremov YM, Ulasov I, Shi B. Zou Y, et al. Among authors: lovejoy db. Adv Mater. 2022 Aug;34(33):e2203958. doi: 10.1002/adma.202203958. Epub 2022 Jul 17. Adv Mater. 2022. PMID: 35738390

2

Major Developments in the Design of Inhibitors along the Kynurenine Pathway.

Jacobs KR, Castellano-Gonzalez G, Guillemin GJ, Lovejoy DB. Jacobs KR, et al. Among authors: lovejoy db. Curr Med Chem. 2017;24(23):2471-2495. doi: 10.2174/0929867324666170502123114. Curr Med Chem. 2017. PMID: 28464785 Free PMC article. Review.

3

Inhibiting the kynurenine pathway in spinal cord injury: Multiple therapeutic potentials?

Jacobs KR, Lovejoy DB. Jacobs KR, et al. Among authors: lovejoy db. Neural Regen Res. 2018 Dec;13(12):2073-2076. doi: 10.4103/1673-5374.241446. Neural Regen Res. 2018. PMID: 30323124 Free PMC article. Review.

4

2-hydroxy-1-naphthaldehyde 2-methylthiosemicarbazone.

Lovejoy DB, Richardson DR, Bernhardt PV. Lovejoy DB, et al. Acta Crystallogr C. 2000 Mar;56 ( Pt 3):341-2. doi: 10.1107/S0108270199015140. Epub 2000 Mar 15. Acta Crystallogr C. 2000. PMID: 10777943 Free article. No abstract available.

5

Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders.

Bai MY, Lovejoy DB, Guillemin GJ, Kozak R, Stone TW, Koola MM. Bai MY, et al. Among authors: lovejoy db. Complex Psychiatry. 2021 Aug;7(1-2):19-33. doi: 10.1159/000515066. Epub 2021 Feb 8. Complex Psychiatry. 2021. PMID: 35141700 Free PMC article. Review.

6

Understanding the role of the kynurenine pathway in human breast cancer immunobiology.

Heng B, Lim CK, Lovejoy DB, Bessede A, Gluch L, Guillemin GJ. Heng B, et al. Among authors: lovejoy db. Oncotarget. 2016 Feb 9;7(6):6506-20. doi: 10.18632/oncotarget.6467. Oncotarget. 2016. PMID: 26646699 Free PMC article. Review.

7

Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors.

Yu Y, Kalinowski DS, Kovacevic Z, Siafakas AR, Jansson PJ, Stefani C, Lovejoy DB, Sharpe PC, Bernhardt PV, Richardson DR. Yu Y, et al. Among authors: lovejoy db. J Med Chem. 2009 Sep 10;52(17):5271-94. doi: 10.1021/jm900552r. J Med Chem. 2009. PMID: 19601577 Review. No abstract available.

8

The potential for transition metal-mediated neurodegeneration in amyotrophic lateral sclerosis.

Lovejoy DB, Guillemin GJ. Lovejoy DB, et al. Front Aging Neurosci. 2014 Jul 23;6:173. doi: 10.3389/fnagi.2014.00173. eCollection 2014. Front Aging Neurosci. 2014. PMID: 25100994 Free PMC article. Review.

9

Chelators at the cancer coalface: desferrioxamine to Triapine and beyond.

Yu Y, Wong J, Lovejoy DB, Kalinowski DS, Richardson DR. Yu Y, et al. Among authors: lovejoy db. Clin Cancer Res. 2006 Dec 1;12(23):6876-83. doi: 10.1158/1078-0432.CCR-06-1954. Clin Cancer Res. 2006. PMID: 17145804 Review.

10

The medicinal chemistry of novel iron chelators for the treatment of cancer.

Kovacevic Z, Kalinowski DS, Lovejoy DB, Yu Y, Suryo Rahmanto Y, Sharpe PC, Bernhardt PV, Richardson DR. Kovacevic Z, et al. Among authors: lovejoy db. Curr Top Med Chem. 2011;11(5):483-99. doi: 10.2174/156802611794785190. Curr Top Med Chem. 2011. PMID: 21192781 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

59 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year